Literature DB >> 16289587

Status epilepticus induces time-dependent neuronal and astrocytic expression of interleukin-1 receptor type I in the rat limbic system.

T Ravizza1, A Vezzani.   

Abstract

Interleukin-1beta is rapidly synthesized by glia after the induction of seizures. Recent evidence shows that endogenous IL-1beta has proconvulsant actions mediated by interleukin-1 receptor type I. This receptor also mediates interleukin-1beta effects on neuronal susceptibility to neurotoxic insults. In this study, we investigated the basal and seizure-induced expression of interleukin-1 receptor type I in rat forebrain to identify the cells targeted by interleukin-1beta during epileptic activity. Self-sustained limbic status epilepticus was induced in rats by electrical stimulation of the ventral hippocampus. Interleukin-1 receptor type I immunoreactivity was barely detectable in neurons in control brain tissue. During status epilepticus, interleukin-1 receptor type I was induced in the hippocampal neurons firstly, and several hours later in astrocytes localized in limbic and extralimbic areas. Neuronal interleukin-1 receptor type I expression in the hippocampus outlasted the duration of spontaneous electroencephalographic seizure and was not observed in degenerating neurons. Astrocytic expression occurred transiently, between six and 18 h after the induction of status epilepticus and was invariably found in regions of neuronal damage. These time-dependent, cell- and region-specific changes in interleukin-1 receptor type I expression during status epilepticus suggest that interleukin-1 receptor type I in neurons mediates interleukin-1beta-induced fast changes in hippocampal excitability while interleukin-1 receptor type I receptors in astrocytes may mediate interleukin-1beta effects on neuronal survival in hostile conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16289587     DOI: 10.1016/j.neuroscience.2005.07.063

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  56 in total

Review 1.  Cytokines and brain excitability.

Authors:  Michael A Galic; Kiarash Riazi; Quentin J Pittman
Journal:  Front Neuroendocrinol       Date:  2011-12-27       Impact factor: 8.606

Review 2.  The role of inflammation in epilepsy.

Authors:  Annamaria Vezzani; Jacqueline French; Tamas Bartfai; Tallie Z Baram
Journal:  Nat Rev Neurol       Date:  2010-12-07       Impact factor: 42.937

3.  Neuroinflammatory Nexus of Pediatric Epilepsy.

Authors:  Shruti Bagla; Alan A Dombkowski
Journal:  J Pediatr Epilepsy       Date:  2018-09-03

4.  Emergency Neurological Life Support: Status Epilepticus.

Authors:  Jan Claassen; Joshua N Goldstein
Journal:  Neurocrit Care       Date:  2017-09       Impact factor: 3.210

Review 5.  Emergency Neurological Life Support: Status Epilepticus.

Authors:  Jan Claassen; James J Riviello; Robert Silbergleit
Journal:  Neurocrit Care       Date:  2015-12       Impact factor: 3.210

6.  Neuromodulatory role of endogenous interleukin-1β in acute seizures: possible contribution of cyclooxygenase-2.

Authors:  Robert J Claycomb; Sandra J Hewett; James A Hewett
Journal:  Neurobiol Dis       Date:  2011-08-10       Impact factor: 5.996

7.  A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta.

Authors:  Silvia Balosso; Mattia Maroso; Manuel Sanchez-Alavez; Teresa Ravizza; Angelisa Frasca; Tamas Bartfai; Annamaria Vezzani
Journal:  Brain       Date:  2008-10-24       Impact factor: 13.501

8.  Inhibition of P2X7 Receptor Ameliorates Nuclear Factor-Kappa B Mediated Neuroinflammation Induced by Status Epilepticus in Rat Hippocampus.

Authors:  Cheng Huang; Xiao-Sa Chi; Rui Li; Xin Hu; Hai-Xia Xu; Jin-Mei Li; Dong Zhou
Journal:  J Mol Neurosci       Date:  2017-08-30       Impact factor: 3.444

Review 9.  Causes of CNS inflammation and potential targets for anticonvulsants.

Authors:  Mercé Falip; Xavier Salas-Puig; Carlos Cara
Journal:  CNS Drugs       Date:  2013-08       Impact factor: 5.749

Review 10.  Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside.

Authors:  Avijit Dey; Xu Kang; Jiange Qiu; Yifeng Du; Jianxiong Jiang
Journal:  Trends Pharmacol Sci       Date:  2016-04-06       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.